A DNA Origami-based Bactericide for Efficient Healing of Infected Wounds

Angew Chem Int Ed Engl. 2023 Nov 13;62(46):e202311698. doi: 10.1002/anie.202311698. Epub 2023 Oct 12.

Abstract

Bacteria infection is a significant obstacle in the clinical treatment of exposed wounds facing widespread pathogens. Herein, we report a DNA origami-based bactericide for efficient anti-infection therapy of infected wounds in vivo. In our design, abundant DNAzymes (G4/hemin) can be precisely organized on the DNA origami for controllable generation of reactive oxygen species (ROS) to break bacterial membranes. After the destruction of the membrane, broad-spectrum antibiotic levofloxacin (LEV, loaded in the DNA origami through interaction with DNA duplex) can be easily delivered into the bacteria for successful sterilization. With the incorporation of DNA aptamer targeting bacterial peptidoglycan, the DNA origami-based bactericide can achieve targeted and combined antibacterial therapy for efficiently promoting the healing of infected wounds. This tailored DNA origami-based nanoplatform provides a new strategy for the treatment of infectious diseases in vivo.

Keywords: Bactericide; DNA Origami; Drug Delivery; Infected Wound Healing; Self-Assembly.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Aptamers, Nucleotide* / therapeutic use
  • DNA / therapeutic use
  • Humans
  • Wound Infection* / drug therapy

Substances

  • Anti-Bacterial Agents
  • DNA
  • Aptamers, Nucleotide